Untitled Document
European Gynecologic Oncology Congress


Home  |  Overview  |  Agenda  |  Venue & Location  |  Registration  |  Cancellation  |  Contact
 
 

Target Audience

This congress is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners involved in the diagnosis and management of gynecologic cancers.  

Official Language


The official language of the meeting is English.
 
 
 

Dress Code

Dress code is business casual.
 
 
 

Important Deadlines


19 Jan 2010     Hotel Reservations
19 Jan 2010     Hotel cancellation 
                       free of charge
01 Feb 2010     Registration
01 Feb 2010     Provide names of
                       group delegates

Print Materials

Meeting Overview

This meeting will serve as a valuable forum for the presentation and discussion of newly available data and analyses of ongoing clinical trials thereby providing participants with an update on clinical practice changing therapies in a practical, interactive format fostering discussion, understanding and impacting the care of patients suffering from gynecologic malignancies.
 
The interactive format of the Congress will incorporate typical didactic presentations with a significant number of interactive clinical case discussions. Attendees will have the opportunity to respond to integrated clinical cases and debates through the use of an electronic audience response system.

Learning Objectives

Upon completion of this educational activity, participants should be able to:
•       Assess the impact of human papillomavirus (HPV) vaccines on the screening and prevention of cervical cancer
•       Develop a practical approach to cervical cancer staging and management of recurrent disease
•       Discuss the role of surgery and adjuvant radiotherapy in endometrial cancer
•       Describe the use of systemic therapies in recurrent endometrial cancer
•       Derive the optimal surgical management of ovarian cancer based on disease stage and clinical presentation
•       Identify emerging therapies for ovarian cancer and discuss potential impact on the future management practices
•       Formulate optimal treatment strategies for recurrent ovarian cancer